CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-10 | BARRETT M JAMES Director | Option exercise · Warrant to Purchase Common Stock (right to buy) | −216,046 | 0 | ||
| 2018-05-10 | BARRETT M JAMES Director | Option exercise · Warrant to Purchase Common Stock (right to buy) | −298,406 | 0 | ||
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise | +216,046 | $0.33 | $71K | 4,706,797 |
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Sale | −4,006 | $17.81 | $71K | 4,702,791 |
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise | +298,406 | $0.33 | $98K | 5,001,197 |
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Sale | −5,533 | $17.81 | $99K | 4,995,664 |
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise · Warrant to Purchase Common Stock (right to buy) | −216,046 | 0 | ||
| 2018-05-10 | NEW ENTERPRISE ASSOCIATES 10 L P 10% owner | Option exercise · Warrant to Purchase Common Stock (right to buy) | −298,406 | 0 | ||
| 2018-01-10 | King Rachel K. President, CEO | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2018-01-10 | Thackray Helen M. SVP Clinical Development, CMO | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-10 | Magnani John L. SVP of Research, CSO | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-01-10 | Hahn Brian M. CFO | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2017-12-08 | Thackray Helen M. SVP Clinical Development, CMO | Sale | −2,000 | $15.01 | $30K | 148,615 |
| 2017-09-18 | Thackray Helen M. SVP Clinical Development, CMO | Sale | −2,000 | $13.00 | $26K | 150,615 |
| 2017-06-15 | JUNIUS DANIEL M Director | Grant or award | +3,000 | $11.27 | $34K | 8,000 |
| 2017-06-09 | Andrews Patricia S Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2017-05-25 | BARRETT M JAMES Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-05-25 | PEARSON TIMOTHY R Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-05-25 | Koenig Scott Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2017-05-25 | JUNIUS DANIEL M Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 |
Page 14 of 16 · 305 trades